TREM2 signaling shapes plaque-associated microglial responses, lipid handling, APOE-related state transitions, and plaque compaction in AD. The hypothesis remains biologically strong but should be repositioned after failed standalone agonist results toward genotype- and stage-stratified intervention, likely in combination with amyloid or tau therapies.
No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for TREM2; yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TREM2; APOE; ABCA1.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.